- This topic has 0 replies, 1 voice, and was last updated 1 year ago by
.
FDA launches Coronavirus Treatment Acceleration Program (CTAP)
The U.S. Food and Drug Administration has launched a program to expedite the development of treatments for COVID-19 the Coronavirus Treatment Acceleration Program (CTAP). It is aiming to bring new therapies to sick patients as quickly as possible and support research to further evaluate whether these medical countermeasures are safe and effective for patients.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-accelerate-development-novel-therapies-covid-19
- You must be logged in to reply to this topic.